Covid-19 Coronavirus

COVID-19 vaccine delivery

For Health Professionals

Updated 15 April 2021

COVID-19 Vaccine Information

Manx Care is leading the rollout of the Isle of Man COVID-19 Vaccination programme which commenced in January 2021.

More than 40,000 vaccinations have been administered so far, and invitations continue to be sent to Priority Group 7 (aged 60-64 years) from today to consent and receive a COVID-19 vaccine.

Administered more then 40,000

Immunisation: advice on priority groups for COVID-19 vaccination - GOV.UK (www.gov.uk)

An additional group was added to the priority groups towards the end of February and crews on:

  • Steam Packet
  • Ramsey-based sea freight carrier Mezeron
  • Isle of Man-based crew at flight operator Loganair
  • Air ambulance provider IAS Medical

Received their vaccination earlier than scheduled to protect individuals from serious illness should they pick up the virus which will help to safeguard our critical national transport links.

Please continue to read the sections below which provide health practitioners with detailed guidance, policies and training to support the vaccination programme delivery.

The coronavirus (COVID-19) vaccine is safe and effective. It gives you the best protection against coronavirus.

Receiving the vaccine may help protect you from coronavirus, but it is still important to follow hand and respiratory hygiene advice to keep each other safe.

Information for Health Professionals

The Health Protection team within the Public Health Directorate has recommended this direct link to the UK  PHE document ‘COVID-19 vaccination programme: Information for healthcare practitioners’ for reference.

The guidance is updated frequently so please continue check regularly for changes.

Share this information with your staff, with a caveat stating that staff must follow the Manx Care Protocols as they continue to be made available.

Hospital Policies – Employee Internal Site Link
http://edrmgi/sites/hospital/Pages/Hospital%20Wide.aspx

COVID-19 Public Health Guidance website content
https://covid19.gov.im/public-health-guidance/

Green Book Chapters on COVID-19

Chapter 14

Includes information on:

  • the coronavirus (COVID-19) vaccines
  • the dosage and schedule for the UK
  • recommendations for the use of the vaccine

COVID-19: the green book, chapter 14a - GOV.UK (www.gov.uk)

Also see

Chapter 8

Vaccine safety and adverse events following immunisation: the green book, chapter 8

MHRA and Coronavirus Yellow Card Reporting

The MHRA is working closely with DHSC and other healthcare partners on COVID-19.

They are prioritising work including:

  • supporting and authorising the development of vaccines
  • clinical trials of new medicines
  • managing the supply of medicines and healthcare products

They also provide information to patients, manufacturers and healthcare professionals through our established information channels and alert systems.

For guidance visit:

MHRA guidance on coronavirus (COVID-19) - GOV.UK (www.gov.uk)

Report any suspected side effects of vaccines and medicines through the Yellow Card scheme.

By calling: 0800 731 6789; or

Registering and downloading the Yellow Card app; or

Online at: www.coronavirus-yellowcard.mhra.gov.uk 

MHRA Regular reports

Daily COVID-19 Vaccinations Statistics

COVID-19 vaccination statistics

MHRA Weekly report covering adverse reactions to approved COVID-19 vaccines is published on a Thursday.

Further reading

Authorised vaccines and Patient Information Leaflet (PIL)

Information for healthcare professionals and the public about the approved COVID-19 Vaccines

Pfizer/BioNTech COVID-19 vaccine
Authorised for use with UK and IOM on 2 December 2020

Oxford University/AstraZeneca COVID-19 vaccine
Authorised for use with UK and IOM on 30 December 2020

Moderna COVID-19 vaccine
Authorised for use with UK and IOM for use on 8 January 2021

Vaccination Cards are supplied with each dose of vaccine.

These will be given to the recipient with information about their vaccine: the date given and the date of appointment for their second dose.

Registration process for health professionals

To help ensure that Manx Care is able to deliver a large-scale vaccination programme without significantly impacting on other vital services, we are asking for health professionals who are interested in taking part in the delivery of this vaccination programme to register by

email to lead@gov.im 

Call Learning, Education and Development  
Tel: +44 1624 685716.

Please provide:

Your name 
Email address
Contact telephone number

Those selected to participate in the vaccination programme will receive full training and appropriate supervision. Personal protective equipment (PPE) will also be made available.

COVID-19 Vaccination Training

Training modules are now available to health and care workforce involved in the national COVID-19 vaccination programme to provide them with the necessary knowledge and skills required to confidently promote high uptake of the vaccine and to deliver the COVID-19 vaccination programme effectively.

Isle of Man Government Health Professionals

Should visit E-Learn Vannin, choose
Prospectus Section 6 – Complete the COVID-19 Training

Then complete the following training modules

  • Emergency Treatment Of Anaphylactic Reactions
  • Core Knowledge for COVID-19 Vaccinators
  • Core Knowledge for COVID-19 Vaccinators - Assessment
  • Immunisations for COVID-19 Vaccinators
  • Basic Life Support (BLS) and Automated External Defibrillation for COVID 19 Vaccinators
  • COVID-19 mRNA Vaccine BNT162b2
  • COVID-19 mRNA Vaccine BNT162b2 - Assessment
  • COVID-19 Vaccine AstraZeneca
  • COVID-19 Vaccine AstraZeneca - Assessment
  • Aseptic Non-Touch Technique (ANTT) Training for COVID Vaccinators
  • Patient Group Directions for COVID-19 Vaccinators
  • How to use a combined throat and nose swab kit to test COVID-19

Other COIVD-19 training is also available for:

  • Contact Tracing registration training
  • COVID-19 Training for Doctors (Face to Face)
  • Gloucester Trust: Respiratory Care & Assessment
  • Infection Prevention & Control COVID-19
  • Putting on/taking off PPE Videos

If you do not already have access to this training area or experience any problems whilst  completing this training, please visit https://hr.gov.im/lead/e-learn-vannin/ for more details.

If you do not have access to the Isle of Man Government E-Learn Vannin training tool, please visit E Learning for Health Care online training tool at COVID-19 Vaccination - e-Learning for Healthcare (e-lfh.org.uk)

Also see the Training Resources section for further reference materials
https://www.gov.uk/government/collections/covid-19-vaccination-programme

Patient Group Directives (PGDs)

Publications approval reference 001559

Patient Group Direction for Covid-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech)

Reference no: COVID-19 mRNA vaccine BNT162b2 PGD
Version no: v03.00
Valid from: 22 March 2021
Review date: 1 October 2021
Expiry date: 31 March 2022

Patient Group Direction for COVID-19 Vaccine AstraZeneca, (ChAdOx1-S [recombinant])

Reference no: COVID-19 Vaccine AstraZeneca PGD
Version no: v02.00
Valid from: 22 March 2021
Review date: 1 October 2021
Expiry date: 31 March 2022

Frontline staff receiving the vaccination

Manx Care Occupational Health Service

COVID-19 Vaccination for DHSC and Other Exposed Workers Policy (PDF, 68KB)

COVID-19 Medical Vulnerability Assessments Form (PDF, 155KB)

Details on vaccines and Patient information leaflet (PIL)

Pfizer/BioNTech COVID-19 vaccine
Authorised for use with UK and IOM on 2 December 2020

Oxford University/AstraZeneca COVID-19 vaccine
Authorised for use with UK and IOM on 30 December 2020

Moderna COVID-19 vaccine
Authorised for use with UK and IOM for use on 8 January 2021

Supporting literature

IMM92a 0121 – COVID-19 vaccination: Protection for healthcare workers A5 (PDF, 1MB)

IMM94a 0121 – COVID-19 vaccination: Protection for social care workers A5 (PDF, 1MB)

What to expect after your vaccination

Further guidance on the Isle of Man Vaccination Programme can be viewed here

https://covid19.gov.im/vaccination-information/

 

Back to top